2004
New Carotid Stent System Offers Minimally Invasive Alternative to Open Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced a collaboration...
Company to Reiterate Third Quarter and Full-Year Guidance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call today, Thursday, , at...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its regularly scheduled mid-quarter conference call to provide an update on the...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Advanced Leads and Lead Delivery System Further Strengthen Company''s Heart Failure Portfolio Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
U.S. Food and Drug Administration Advisory Committee Approval Based on Data from Company''s Landmark COMPANION Heart Failure Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation...
New Rapid-Exchange Dilatation Catheter Provides Foundation for Successful Interventional Procedures Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the...
Sales led by strong growth in worldwide implantable defibrillators Worldwide implantable defibrillator revenue of $456 million, up 21 percent Worldwide pacemaker revenue of $183 million, up 7 percent
Innovative System Combines Treatments for Heart Failure, Atrial Arrhythmias and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
INDIANAPOLIS-Guidant Corporation (NYSE: GDT) will conduct a live webcast of its second quarter 2004 earnings conference call on Thursday, July 22 at 11:00 a.m. EDT. The company will issue a press...
Company Makes Staged Equity Investment in Miravant Medical Technologies Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced an agreement with Miravant...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced conference call today, , at 4:30 PM EDT. On the call, the company will provide an update on its lead drug...
Webcast Scheduled for July 1 at 4:30 PM EDT Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its previously announced conference call on Thursday, July 1,...
Guidant Seeks to Expand User Labeling, Including Indications, for Cardiac Resynchronization Therapy Defibrillators Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will participate in the Goldman Sachs 25th Annual Global Healthcare Conference on Tuesday, June 8, in Laguna Nigel, Calif.
Guidant Customers in Europe to Obtain Access to Pioneering Technology Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the company has begun...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today reaffirmed on the company''s mid-quarter conference call its previously stated guidance for the second quarter - sales in the range of...
MULTI-LINK MINI VISION Coronary Stent System and VOYAGER Coronary Dilatation Catheter Enable Physicians to More Easily Treat Patients with Complex Coronary Artery Disease Indianapolis, Ind. and...
Mid-Quarter Conference Call Tomorrow at 9:00 AM EDT Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call tomorrow, May 27, 2004, at...
SPIRIT FIRST 30-Day and FUTURE II One-Year Results Continue to Support Benefit of Everolimus Eluting Coronary Stents Indianapolis, Ind., and Paris - Guidant Corporation (NYSE: GDT) today announced...
Evalve, Inc.''s Innovative Technology Designed to Offer New Treatment Option for Debilitating Condition Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...
Trial Results Support Therapy for Extending and Improving the Lives of People with Advanced Heart Failure Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
Dollens will Remain President and CEO Until His Retirement; Guido J. Neels Elevated to Chief Operating Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will announce today at its...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a second quarter dividend of $0.10 per share on outstanding common stock. This...